Anti-Mouse MAdCAM-1 (MECA-89) – Purified in vivo PLATINUMTM Functional Grade
Anti-Mouse MAdCAM-1 (MECA-89) – Purified in vivo PLATINUMTM Functional Grade
Product No.: M1421
Clone MECA-89 Target MADCAM-1 Formats AvailableView All Product Type Hybridoma Monoclonal Antibody Alternate Names Mucosal addressin cell adhesion molecule-1 Isotype Rat IgG2a κ Applications B , FA , FC , IF , IHC , IP , WB |
Antibody DetailsProduct DetailsReactive Species Mouse Host Species Rat Recommended Isotype Controls Recommended Isotype Controls Recommended Dilution Buffer Immunogen Mouse mesenteric and peripheral lymph node cells Product Concentration ≥ 5.0 mg/ml Endotoxin Level ≤ 1.0 EU/mg as determined by the LAL method Purity ≥95% by SDS Page ⋅ ≥95% monomer by analytical SEC Formulation This monoclonal antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.2 - 7.4 with no carrier protein, potassium, calcium or preservatives added. Due to inherent biochemical properties of antibodies, certain products may be prone to precipitation over time. Precipitation may be removed by aseptic centrifugation and/or filtration. State of Matter Liquid Product Preparation Functional grade preclinical antibodies are manufactured in an animal free facility using in vitro cell culture techniques and are purified by a multi-step process including the use of protein A or G to assure extremely low levels of endotoxins, leachable protein A or aggregates. Pathogen Testing To protect mouse colonies from infection by pathogens and to assure that experimental preclinical data is not affected by such pathogens, all of Leinco’s Purified Functional PLATINUM<sup>TM</sup> antibodies are tested and guaranteed to be negative for all pathogens in the IDEXX IMPACT I Mouse Profile. Storage and Handling Functional grade preclinical antibodies may be stored sterile as received at 2-8°C for up to one month. For longer term storage, aseptically aliquot in working volumes without diluting and store at ≤ -70°C. Avoid Repeated Freeze Thaw Cycles. Regulatory Status Research Use Only Country of Origin USA Shipping 2 - 8°C Wet Ice Additional Applications Reported In Literature ? FA IHC IF IP WB FC B Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change. DescriptionDescriptionSpecificity MECA-89 activity is directed against mouse MAdCAM-1. Background MAdCAM-1 is a cell adhesion leukocyte receptor expressed by mucosal venules that helps direct lymphocyte traffic into mucosal tissues and regulates the passage and retention of leukocytes1, 2. MAdCAM-1 binds integrin receptor α4β7 and L-selectin2, 3, 4. Two alternatively spliced isoforms of MAdCAM-1 exist5, both of which are capable of binding α4β72. MECA-89 was generated by immunizing Wistar rats with endothelial cells isolated from BALB/c mesenteric and peripheral lymph nodes 6. Immunohistological screening of hybridomas yielded two mAbs, MECA-367 and MECA-89, that stain high endothelial venules (HEVs) in mucosal lymphoid organs and Peyer’s patches, but not peripheral lymph nodes (axillary, brachial, popliteal, and inguinal). Immunofluorescence staining of high endothelial cells shows that both MECA-367 and MECA-89 react with antigens on the cell surface. The epitopes for MECA-367 and MECA-89 are distinct. MECA-367 recognizes the N-terminal immunoglobulin domain of MAdCAM-l, and MECA-89 recognizes the second immunoglobulin domain 4,5. MECA-89 reacts with the same vessels as MECA-367 and binds to isolated MECA-367 antigen; however, unlike MECA-367 it has no effect on lymphocyte binding 6. Additionally, MECA-89 has no effect on MAdCAM-1 binding to α4β7 in vitro 7, but L-selectin dependent adhesion is lost in the presence of MECA-89 4. Additionally, MECA-89 has no significant effect on activated cells, but all interactions are inhibited following subsequent injection of anti-α4 Fab fragments 4. In vivo, MECA-89 inhibits L-selectin-dependent rolling but not direct α4β7-dependent attachment of Mn2+ activated lymphocytes. Antigen Distribution MAdCAM-1 is a cell surface glycoprotein selectively expressed on high endothelial venules of mucosal lymphoid organs and Peyer’s patches as well as lamina propria venules. Ligand/Receptor Integrin a4ß7, CD62L NCBI Gene Bank ID UniProt.org Research Area Cell Adhesion . Cell Biology . Immunology Leinco Antibody AdvisorPowered by AI: AI is experimental and still learning how to provide the best assistance. It may occasionally generate incorrect or incomplete responses. Please do not rely solely on its recommendations when making purchasing decisions or designing experiments. Clone MECA-89 is used in in vivo mouse studies primarily for targeting MAdCAM-1 (Mucosal Vascular Addressin Cell Adhesion Molecule 1). MAdCAM-1 is a molecule expressed on the surface of endothelial cells in mucosal venules and is involved in homing of lymphocytes to mucosal tissues. The MECA-89 antibody clone is specifically designed to recognize and bind to this molecule. Use in Research
Characteristics of MECA-89
Overall, the MECA-89 clone is a valuable tool for studying the role of MAdCAM-1 in immune responses and disease models in mice. Recommended Storage Temperature for Sterile Packaged Clone MECA-89Short-term Storage (?1 month): Long-term Storage (>1 month): Summary Table
Additional Recommendations
In summary: Based on the available information, MECA-89 is primarily used as an anti-MAdCAM-1 (Mucosal vascular addressin cell adhesion molecule-1) antibody in research applications. While the search results don't provide extensive details about other antibodies commonly used alongside MECA-89, there are several key reagents and controls that are typically employed with this antibody. Control Antibodies and ReagentsThe most commonly mentioned companion reagent is the Purified Rat IgG2a ? Isotype Control (Cat. No. 559073), which serves as the recommended isotype control for MECA-89 in immunohistochemistry applications. This control is essential for validating the specificity of MECA-89 staining and ensuring that observed binding is antigen-specific rather than due to non-specific interactions. Detection and Amplification SystemsFor immunohistochemical applications, MECA-89 is frequently used with a three-step detection system that includes:
Alternative Conjugated FormsMECA-89 is also available in conjugated formats, including a biotin-conjugated version (Cat. No. 553808) for flow cytometric applications. This provides researchers with flexibility in their experimental design and detection methods. Application-Specific ConsiderationsThe antibody is routinely tested for flow cytometry applications and has been validated for immunohistochemistry on acetone-fixed frozen sections. It's particularly effective for staining mucosal lymphoid tissue, lamina propria, and splenic sinus lining cells in mouse tissues, making it valuable for studies investigating mucosal immunity and lymphocyte homing mechanisms. The search results indicate that MECA-89 requires specific tissue preparation methods, as it's not recommended for formalin-fixed paraffin-embedded sections, which may influence the choice of complementary reagents and protocols used in conjunction with this antibody. Key findings from scientific literature citing clone MECA-89 focus on the mecA genes role and clonal dissemination among methicillin-resistant Staphylococcus aureus (MRSA), mapping its genetic context, and its association with antimicrobial resistance.
In summary, clone MECA-89 citations have advanced the understanding of MRSAs global spread, the genetic mobility of mecA, and how resistance determinants integrate into widely distributed pandemic clones, shaping public health responses to staphylococcal infections. References & Citations1. https://www.uniprot.org/uniprotkb/Q61826/entry
2. Schiffer SG, Day E, Latanision SM, et al. Biochem Biophys Res Commun. 216(1):170-176. 1995. 3. Berlin C, Berg EL, Briskin MJ, et al. Cell. 74(1):185-195. 1993. 4. Bargatze RF, Jutila MA, Butcher EC. Immunity. 3(1):99-108. 1995. 5. Briskin MJ, McEvoy LM, Butcher EC. Nature. 363(6428):461-464. 1993. 6. Streeter PR, Berg EL, Rouse BT, et al. Nature. 331(6151):41-46. 1988. 7. Nakache M, Berg EL, Streeter PR, et al. Nature. 337(6203):179-181. 1989. Technical ProtocolsCertificate of Analysis |
Related Products
Formats Available
Prod No. | Description |
---|---|
M1422 | |
M1425 | |
M1423 | |
M1424 | |
M1420 | |
M1421 |
